Objective:

To examine the contributions of Sophie Spitz to the understanding and classification of Spitz nevi and their evolution in dermatopathology.

Key Findings:

• Sophie Spitz's 1948 paper transformed the understanding of pediatric melanoma, establishing the term 'Spitz nevus.'
• Molecular determinants such as HRAS mutations and kinase fusions have been identified, differentiating Spitz nevi from other melanocytic tumors.
• The classification of melanocytoma was solidified in 2022, aligning molecular biology with histology and clinical behavior.

Interpretation:

Spitz's work marked a significant shift in dermatopathology, moving from morphology-based diagnosis to a molecularly integrated approach, improving patient outcomes.

Limitations:

• Initial resistance to Spitz's findings delayed acceptance and integration into clinical practice.
• Ongoing research is needed to further refine the classification and management of Spitz nevi.

Conclusion:

Sophie Spitz's legacy continues to influence dermatopathology, highlighting the importance of integrating molecular biology into clinical practice for better diagnosis and treatment of melanocytic lesions.